Rchr
J-GLOBAL ID:200901086249406210   Update date: Nov. 14, 2024

Ogawa Kazuma

オガワ カズマ | Ogawa Kazuma
Affiliation and department:
Research field  (3): Radiology ,  Other ,  Pharmaceuticals - analytical and physicochemistry
Research keywords  (4): 放射性薬剤 ,  Bone ,  Cancer ,  Radiopharmaceutical
Research theme for competitive and other funds  (36):
  • 2022 - 2026 原発性アルドステロン症における新治療戦略ー安全かつ高奏功な根本治療の開発
  • 2022 - 2025 development of photochemical reactions using cyclic carbonyl compoundsl
  • 2022 - 2025 Nanobody and PROTACs fused theranostics agents for pancreatic cancer
  • 2021 - 2025 局所療法を融合した発展型ラジオセラノスティクス用プローブ開発研究
  • 2020 - 2023 放射性金属を用いた包括的な腫瘍診断・治療薬剤の開発研究
Show all
Papers (143):
  • Masayuki Munekane, Miki Ozaki, Yuri Mitani, Natsuki Sakaida, Kohei Sano, Toshihide Yamasaki, Takahiro Mukai, Kenji Mishiro, Takeshi Fuchigami, Kazuma Ogawa. Development of Radiolabeled Probes with Improved Imaging Contrast by Releasing Urinary Excretable Radiolabeled Compounds from Thermosensitive Liposomes in the Blood. Molecular pharmaceutics. 2024. 21. 11. 5728-5735
  • Kazuma Ogawa, Kota Nishizawa, Kenji Mishiro, Masayuki Munekane, Takeshi Fuchigami, Hiroaki Echigo, Hiroshi Wakabayashi, Seigo Kinuya. Differences in the Renal Accumulation of Radiogallium-Labeled (Glu)14 Peptides Containing Different Optical Isomers of Glutamic Acid. Molecules (Basel, Switzerland). 2024. 29. 17
  • Hiroaki Echigo, Masayuki Munekane, Takeshi Fuchigami, Kohshin Washiyama, Kenji Mishiro, Hiroshi Wakabayashi, Kazuhiro Takahashi, Seigo Kinuya, Kazuma Ogawa. Optimizing the pharmacokinetics of an 211At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor. European journal of nuclear medicine and molecular imaging. 2024
  • Kazuma Ogawa, Kota Nishizawa, Kenji Mishiro, Nurmaya Effendi, Takeshi Fuchigami, Masayuki Munekane, Hiroshi Wakabayashi, Seigo Kinuya. Synthesis and Evaluation of Radiogallium Labeled Bone-Imaging Probes Using Oligo-γ-Carboxy Glutamic Acid Peptides as Carriers to Bone. Molecular pharmaceutics. 2024
  • Masayuki Munekane, Takeshi Fuchigami, Kazuma Ogawa. Recent advances in the development of 225Ac- and 211At-labeled radioligands for radiotheranostics. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry. 2024
more...
MISC (81):
more...
Professional career (2):
  • Doctor of Pharmaceutical Sciences (Kyoto University)
  • 博士(薬学) (京都大学)
Work history (5):
  • 2019 - 現在 Kanazawa University
  • 2009 - 2019 Kanazawa University
  • 2007 - 2009 Kanazawa University
  • 2004 - 2007 Kanazawa University
  • 2002 - 2004 Kyoto Prefectural University of Medicine
Awards (4):
  • 2019/03 - 日本薬学会 学術振興賞
  • 2011 - 日本薬学会北陸支部 学術奨励賞
  • 2006 - 第3回日本核医学会研究奨励賞
  • 2006 - The Third Best Paper Award for Young Researcher (The Japanese Society of Nuclear Medicine)
Association Membership(s) (9):
日本癌学会 ,  米国核医学会 ,  日本薬学会 ,  日本核医学会 ,  The Japanese Cancer Association ,  THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM ,  欧州核医学会 ,  日本分子イメージング学会 ,  THE JAPAN SOCIETY FOR ANALYTICAL CHEMISTRY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page